Ortin Global Limited has announced that its board of directors will convene on February 14, 2026, to review and consider the company's unaudited financial results for the third quarter of fiscal year 2026. The meeting will take place at the company's registered office in Hyderabad, Telangana.

Meeting Details and Regulatory Compliance

The board meeting has been scheduled in accordance with Regulation 29 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company formally notified both major stock exchanges about this upcoming meeting on February 5, 2026.

Agenda Items

The board meeting will focus on two main agenda items:

• Financial Results Review: Consideration of unaudited financial results for the quarter and nine months ended December 31, 2025
• Additional Business: Any other business matters with the permission of the chairperson

Company Information

Ortin Global Limited, formerly known as Ortin Laboratories Limited, operates from its registered office located at D. No. 1-8-305, Ground Floor, Chikkadpally, Musheerabad, Hyderabad-500020, Telangana. The company is incorporated under CIN: L68200TG1986PLC006885 and is listed on both BSE (Scrip Code: 539287) and NSE (Symbol: ORTINGLOBE).

Stock Exchange Notification

The announcement was signed by S. Murali Krishna Murthy, Managing Director (DIN: 00540632), and submitted to both the Bombay Stock Exchange and National Stock Exchange of India Limited. This notification ensures compliance with mandatory disclosure requirements for listed companies regarding board meetings that will consider financial results.

The company maintains its corporate communications through email at info@ortinlabsindia.com and operates its official website at www.ortinlabsindia.com . Stakeholders and investors can expect the financial results to be announced following the board meeting on February 14, 2026.

Ortin Global , formerly known as Ortin Laboratories Limited, has announced an Extraordinary General Meeting (EGM) to be held on August 25, 2025, at 3:00 PM through video conferencing. The meeting aims to address several key appointments and changes in the company's leadership structure.

Board Appointments and Remuneration

The EGM agenda includes five special resolutions, primarily focusing on the appointment of new directors and changes in executive roles:

1. Mr. Sarang Balbhimrao Patodekar is proposed to be appointed as Chairperson and Independent Director for a 5-year term from July 10, 2025, to July 9, 2030.

2. Mr. Ajay Vishwakarma and Ms. Mounika Pammi are set to be appointed as Independent Directors for similar 5-year terms.

3. Mr. Prashant Prakash Sawant and Mrs. Prakruti Prashant Sawant are to be appointed as Whole-time Directors for 3-year terms from July 10, 2025, to July 9, 2028, each with a proposed monthly remuneration of Rs. 55,000.00.

Financial Performance

The pharmaceutical company reported a turnover of Rs. 602.03 lakhs for the financial year 2024-25, with a net loss of Rs. 9.36 lakhs. This performance comes in the context of the company's recent rebranding from Ortin Laboratories Limited to Ortin Global Limited.

Voting Details

Shareholders can participate in remote e-voting from August 22-24, 2025. The cut-off date for voting eligibility is set as August 18, 2025. The company has engaged KFin Technologies Limited to provide the e-voting facility.

New Leadership Profiles

Mr. Sarang Balbhimrao Patodekar

• Over 20 years of expertise in Marketing, Sales, and Team Management across CIS nations
• M.Sc (M.Tech) in Computers from Ukraine
• Strong international ties in infrastructure, railways, nanotechnologies, and defense

Mr. Ajay Vishwakarma

• Seasoned Senior Property Consultant with over 14 years of experience in real estate and construction
• Holds a Diploma in Building Maintenance

Ms. Mounika Pammi

• More than 15 years of leadership experience across marketing, insurance, administration, CSR, and strategic consulting
• MBA in Marketing
• Previously served as MD of MNRG Technologies

Mr. Prashant Prakash Sawant

• Engineer by education
• Former Vice President of JP Morgan Chase
• Expertise in Technical Analysis and understanding of domestic and international commodities markets

Mrs. Prakruti Prashant Sawant

• Software professional with a Masters in Computer Applications (MCA)
• Strong leadership and team management skills

The EGM marks a significant step in Ortin Global Limited's corporate governance and leadership structure, potentially setting the stage for the company's future strategic direction and growth plans.